| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) Klionsky Autophagy 17 (1), 2021 | 10775 | 2021 |
| Machine learning applications in cancer prognosis and prediction K Kourou, TP Exarchos, KP Exarchos, MV Karamouzis, DI Fotiadis Computational and structural biotechnology journal 13, 8-17, 2015 | 3378 | 2015 |
| Head and neck cancer A Argiris, MV Karamouzis, D Raben, RL Ferris The Lancet 371 (9625), 1695-1709, 2008 | 2525 | 2008 |
| First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised … YY Janjigian, K Shitara, M Moehler, M Garrido, P Salman, L Shen, ... The Lancet 398 (10294), 27-40, 2021 | 1773 | 2021 |
| Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets PA Konstantinopoulos, MV Karamouzis, AG Papavassiliou Nature reviews Drug discovery 6 (7), 541-555, 2007 | 614 | 2007 |
| Immunotherapy for pancreatic cancer: A 2020 update D Schizas, N Charalampakis, C Kole, P Economopoulou, E Koustas, ... Cancer treatment reviews 86, 102016, 2020 | 363 | 2020 |
| Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead WH Goodson III, L Lowe, DO Carpenter, M Gilbertson, A Manaf Ali, ... Carcinogenesis 36 (Suppl_1), S254-S296, 2015 | 344 | 2015 |
| A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer EG Iliopoulou, P Kountourakis, MV Karamouzis, D Doufexis, A Ardavanis, ... Cancer immunology, immunotherapy 59, 1781-1789, 2010 | 314 | 2010 |
| Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy P Sarantis, E Koustas, A Papadimitropoulou, AG Papavassiliou, ... World journal of gastrointestinal oncology 12 (2), 173, 2020 | 295 | 2020 |
| Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer K Shitara, JA Ajani, M Moehler, M Garrido, C Gallardo, L Shen, ... Nature 603 (7903), 942-948, 2022 | 254 | 2022 |
| Global cancer control: responding to the growing burden, rising costs and inequalities in access GW Prager, S Braga, B Bystricky, C Qvortrup, C Criscitiello, E Esin, ... ESMO open 3 (2), e000285, 2018 | 253 | 2018 |
| Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas MV Karamouzis, JR Grandis, A Argiris Jama 298 (1), 70-82, 2007 | 221 | 2007 |
| Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial DE Heron, RL Ferris, M Karamouzis, RS Andrade, EL Deeb, S Burton, ... International Journal of Radiation Oncology* Biology* Physics 75 (5), 1493-1500, 2009 | 187 | 2009 |
| Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors MV Karamouzis, PA Konstantinopoulos, AG Papavassiliou The lancet oncology 10 (7), 709-717, 2009 | 154 | 2009 |
| CD4+ CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patients SA Perez, MV Karamouzis, DV Skarlos, A Ardavanis, NN Sotiriadou, ... Clinical Cancer Research 13 (9), 2714-2721, 2007 | 138 | 2007 |
| Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer A Argiris, MV Karamouzis, WE Gooding, BF Branstetter, S Zhong, ... Journal of Clinical Oncology 29 (9), 1140-1145, 2011 | 131 | 2011 |
| Androgen receptor in breast cancer—clinical and preclinical research insights A Anestis, I Zoi, AG Papavassiliou, MV Karamouzis Molecules 25 (2), 358, 2020 | 123 | 2020 |
| Immunotherapy for hepatocellular carcinoma: a 2021 update C Kole, N Charalampakis, S Tsakatikas, M Vailas, D Moris, E Gkotsis, ... Cancers 12 (10), 2859, 2020 | 112 | 2020 |
| Matrix metalloproteinase inhibitors as anticancer agents PA Konstantinopoulos, MV Karamouzis, AG Papatsoris, AG Papavassiliou The international journal of biochemistry & cell biology 40 (6-7), 1156-1168, 2008 | 112 | 2008 |
| Intratumoral doxorubicin in patients with malignant brain gliomas S Voulgaris, M Partheni, M Karamouzis, P Dimopoulos, N Papadakis, ... American journal of clinical oncology 25 (1), 60-64, 2002 | 105 | 2002 |
